Waist circumference
Decrease · small
Reduces fat mass via lipolytic signaling
Literature evidence
Compound library
Vivy evidence dossier
AOD-9604
Also indexed as AOD 9604, hGH 177-191
T3Peptides
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Reference context
Pharmacokinetic context
Half-life4 hr
This field summarizes the library record. Half-life can vary with formulation, indication, and individual clinical context.
Observed relationships
Biomarker context
Triglycerides
Decrease · small
Improves lipid metabolism
Literature evidence
Fasting glucose
Decrease · small
Improves insulin sensitivity
Literature evidence
HbA1c
Decrease · small
Improves glycemic control
Literature evidence
Keep in view
Safety discussion points
AOD-9604 is a fragment of human growth hormone (hGH 177-191) with fat-reducing properties. Not FDA-approved. Available as injectable or oral.
Keep the reference close
Track AOD-9604 in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.